Idt Australia Limited. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Idt Australia Limited. with three other
companies in this sector in AUSTRALIA :
Pharmaxis Ltd
(2021
sales of 22.85 million Australian Dollars [US$16.55 million]
of which 99%
was Mannitol),
Kazia Therapeutics Ltd
(15.22 million Australian Dollars [US$11.03 million]
of which 100%
was Pharmacetical research and development b), and
Mesoblast Ltd
(9.98 million Australian Dollars [US$7.23 million]
of which 100%
was Adult Stem Cell Development).
Sales Analysis.
Idt Australia Limited. reported sales of A$16.93 million (US$12.27 million)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 19.5%
versus 2020, when the company's sales were A$14.17 million.
The sales level in 2021 was fairly close to the level five years ago: in 2016, Idt Australia Limited. had sales
of A$16.91 million.